Gerresheimer AG (GXIG)

Currency in EUR
27.400
-0.320(-1.15%)
Real-time Data·
Earnings results expected in 7 days
GXIG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
27.10027.640
52 wk Range
14.83038.320
Key Statistics
Prev. Close
27.72
Open
27.34
Day's Range
27.1-27.64
52 wk Range
14.83-38.32
Volume
14.66K
Average Volume (3m)
167.58K
1-Year Change
-25.1366%
Book Value / Share
27.69
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GXIG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
27.375
Downside
-0.09%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Gerresheimer AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

2 Buy
7 Hold
4 Sell
Ratings:
13 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 27.375
(-0.09% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Kepler Cheuvreux
Sell23.50-14.67%17.00New Coverage28-08-2026
UBS
Hold28.50+3.49%12.90Upgrade05-08-2026
Deutsche Bank
Hold26.00-5.59%22.00Maintain04-08-2026
Barclays
Sell25.00-9.22%17.00Maintain30-07-2026
Barclays
Sell17.00-38.27%19.00Maintain07-07-2026

Gerresheimer AG Earnings Call Summary for Q2/2026

  • Q2 adjusted EBITDA surged 52% sequentially to €102M, though revenue fell 5.9% YoY to €578M; free cash flow remained negative at €92M.
  • Company maintained FY2026 guidance: revenue in lower half of €2.3B-€2.4B range, EBITDA margin 17%-18%, negative FCF of €50M-€100M.
  • Gerresheimer advancing asset sales of Centor (Oct 2026) and Primary Packaging Plastics (H1 2027) to reduce €2B+ debt burden.
  • Transformation program targeting €50M-€70M annualized EBITDA improvement by end-2027, with full impact expected from 2028 onward.
  • Shares rose 4.59% to $28.70 on sequential recovery; management expects stronger H2 performance driven by normal seasonality and flu demand.
Last Updated: 30-09-2026, 07:26 pm
Read Full Transcript

Earnings

Latest Release
30-09-2026
EPS / Forecast
0.24 / 0.65
Revenue / Forecast
589.8M / 601M
EPS Revisions
Last 90 days

GXIG Income Statement

Compare GXIG to Peers and Sector

Metrics to compare
GXIG
Peers
Sector
Relationship
P/E Ratio
−2.3x13.8x−0.4x
PEG Ratio
0.000.110.00
Price/Book
1.0x1.5x2.6x
Price / LTM Sales
0.4x1.0x3.0x
Upside (Analyst Target)
−1.2%28.3%56.4%
Fair Value Upside
Unlock14.8%7.9%Unlock

Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization, and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Employees
13528
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
8.81M25.50%254.85M
Other Institutional Investors
18.60M53.84%538.15M
Public Companies & Retail Investors
7.14M20.67%206.58M
Total
34.54M100.00%999.59M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
The Goldman Sachs Group, Inc.11.89%41,06,4801,18,842
Goldman Sachs Asset Management, L.P.8.75%30,21,12987,431

FAQ

What Is the Gerresheimer AG (GXIG) Share Price Today?

The Gerresheimer AG share price today is 27.400.

What is the current Gerresheimer AG (GXIG) share price and day range?

As of 02-10-2026, the Gerresheimer AG share price is 27.400, with a previous close of 27.720. The share price has ranged from 27.100 to 27.640 today, while the 52-week range spans from 14.830 to 38.320.

What Is the Gerresheimer AG Market Cap?

As of today, Gerresheimer AG market cap is 1.000B.

What Is the Gerresheimer AG (GXIG) Share Price Target?

The average 12-month share price target for Gerresheimer AG is 27.375, with a high estimate of 46 and a low estimate of 20. 2 analysts recommend buying, while 4 suggest selling, with an overall rating of Neutral and -0.09% Downside potential.

What Is Gerresheimer AG's Earnings Per Share (TTM)?

The Gerresheimer AG EPS (TTM) is -11.859.

When Is the Next Gerresheimer AG Earnings Date?

Gerresheimer AG will release its next earnings report on 09-10-2026.

From a Technical Analysis Perspective, Is GXIG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

What Stock Exchange Does Gerresheimer AG Trade On?

Gerresheimer AG is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for Gerresheimer AG?

The stock symbol for Gerresheimer AG is "GXIG."

How Many Times Has Gerresheimer AG Stock Split?

Gerresheimer AG has split 0 times.

How Many Employees Does Gerresheimer AG Have?

Gerresheimer AG has 13528 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.